Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.110
+0.100 (2.49%)
At close: Mar 9, 2026, 4:00 PM EDT
4.010
-0.100 (-2.43%)
After-hours: Mar 9, 2026, 4:19 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $729.57 million as of March 9, 2026. Its market cap has increased by 82.68% in one year.
Market Cap
729.57M
Enterprise Value
659.46M
1-Year Change
82.68%
Ranking
Category
Stock Price
$4.11
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $729.57M, a decrease of -55.17%. That is a compound annual growth rate of -21.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 710.09M | 15.59% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 769.13M |
| Bright Minds Biosciences | 762.41M |
| Lexicon Pharmaceuticals | 730.31M |
| Gyre Therapeutics | 700.76M |
| ProKidney | 691.92M |
| Theravance Biopharma | 687.62M |
| Tectonic Therapeutic | 673.52M |
| MiMedx Group | 668.55M |